BMEA vs BMRN
Biomea Fusion Inc (BMEA) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
BMEA does not have a complete income-statement cache yet.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
BMEA currently screens at market cap $94.7M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the BMEA and BMRN stock pages for the full models.
Not investment advice.